Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001964306-25-000292
Filing Date
2025-07-28
Accepted
2025-07-28 17:38:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5764
  Complete submission text file 0001964306-25-000292.txt   7242
Mailing Address C/O MIRAGEN THERAPEUTICS, INC. 6200 LOOKOUT ROAD, #100 BOULDER CO 80301
Business Address
Levy Adam Scott (Reporting) CIK: 0001693134 (see all company filings)

 

Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Subject) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41614 | Film No.: 251156835
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)